CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Hon. Irene Patricia Murphy Keeley

Article III Federal Judge

WVND

Time to Trial

Milestone

680 days

Nat'l Avg: 720d (40d faster)

Time to Markman

Claim Const.

1104 days

Filing to Markman Order

Magistrate Adoption

R&R Tendency

88.0%

Adopts R&R recommendations

Total Patent Cases

0 active

39

18 unique patents

Motion Grant Rates vs. National Average

Compares Hon. Irene Patricia Murphy Keeley against federal district court baseline

Interactive

Speed to Milestone Benchmarks (Days)

Empirical duration from complaint filing to critical procedural milestones

Pacing Radar

Patent Motion Disposition Details

Empirical judicial rulings extracted directly from database records

Empirical Rulings
Motion to Dismiss (12(b)(6)) 0 Granted / 0 Denied (0 total filings)
Grant Rate: 0.0% Denial Rate: 0.0%
Baseline: 38.0%
Motion to Dismiss (ยง 101 / Alice) 0 Granted / 0 Denied (0 total filings)
Grant Rate: 0.0% Denial Rate: 0.0%
Baseline: 46.0%
Motion to Transfer Venue (ยง 1404) 2 Granted / 0 Denied (6 total filings)
100.0%
Grant Rate: 100.0% Denial Rate: 0.0%
Baseline: 45.0%
Motion to Stay Pending PTAB/IPR 13 Granted / 0 Denied (34 total filings)
100.0%
Grant Rate: 100.0% Denial Rate: 0.0%
Baseline: 65.0%
Motion for Summary Judgment 2 Granted / 0 Denied (32 total filings)
100.0%
Grant Rate: 100.0% Denial Rate: 0.0%
Baseline: 42.0%

Recent Patent Cases Presided over by Hon. Irene Patricia Murphy Keeley

Showing first 5 cases by default. Click 'View More' to expand.

Total: 39
Case Name & Docket Court Filing Date Status Patents Action
Boehringer Ingelheim Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. 5:20-cv-00023 WVND 2020-02-05 Terminated 0 View Case →
Japan Tobacco Inc. v. Mylan Pharmaceuticals Inc. 1:19-cv-00012 WVND 2019-01-24 Terminated 0 View Case →
Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. 1:18-cv-00226 WVND 2018-12-19 Terminated 0 View Case →
Bausch Health US, LLC v. Mylan Pharmaceuticals Inc. 1:18-cv-00184 WVND 2018-09-27 Terminated 0 View Case →
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. 1:17-cv-00217 WVND 2017-12-15 Terminated 1 View Case →

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc